Company News: J&J nixes production of heart stent, Sanofi pairs with Audion

Share this article:

Johnson & Johnson company Cordis has announced that it will discontinue the development of the Nevo Sirolimus-Eluting Coronary Stent in order to focus on other cardiovascular therapies that are more in patient demand. Cordis will also halt production of Cypher and Cypher Select Plus Sirolimus-Eluting Coronary Stents by the end of 2011, according to a release.

Recently rebranded big pharma Sanofi has announced a two-year research partnership with biopharma company Audion Therapeutics with the objective of developing potential treatments for hearing loss. The collaboration will utilize technology developed at the Massachusetts Eye and Ear Infirmary – one of the world's leading research facilities devoted to the study of hearing and deafness – for the optimization of small molecules by using a regenerative medicine approach.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.